Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 10-Q Report Quarterly Report
  5. 4 Open-market sale 10% owner sold 39,200 shares at $2.92 ($114,464)
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 4 Open-market sale 10% owner sold 194,700 shares at $2.40 ($467,280)
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 8-K Event Shareholder vote results
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 18 · 353 filings